Phase II clinical trials of BCNU )NSC-409962) and bleomycin (NSC-125066) in the treatment of Kaposi's sarcoma.
D000328:Adult; D000368:Aged; D001761:Bleomycin / Q000097:blood / Q000627:therapeutic use*; D002330:Carmustine / Q000097:blood / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous; D012514:Sarcoma, Kaposi / Q000188:drug therapy*
D001761:Bleomycin; D002330:Carmustine